Answers are grounded in this paper and cite their sources.
Introduction: Hepatitis B virus (HBV) is hyperendemic in Nigeria, but national data on HBV awareness and testing among women of reproductive age are lacking. Methods: We analysed data from 38,647 women aged 15–49 years in the 2024 Nigeria Demographic and Health Survey. We estimated survey-weighted prevalence of having heard of HBV (awareness), recent (12-month) testing among aware women, and recent testing among all women, and fitted survey-weighted logistic and multinomial regression models. Results: Awareness was 53.3% (95% CI 52.1–54.6). Among aware women, 12.9% (95% CI 12.1–13.7) had been recently tested, equivalent to 6.9% (95% CI 6.4–7.4) of all women. Higher education, greater wealth and health insurance were associated with both outcomes; women in the richest quintile had higher odds of recent testing than those in the poorest (adjusted odds ratio 3.29, 95% CI 2.31–4.68), and the wealth gradient was steeper for testing than for awareness on the relative scale. Recent testing among all women was lowest in the South South (5.0%) and North West (5.4%). The North West reported the highest awareness (66.5%), but almost all interviews there were in Hausa, and this estimate may partly reflect recognition of a translated term rather than of HBV itself. Socioeconomic gradients in both outcomes differed significantly by zone. Conclusions: HBV testing lags far behind awareness and is concentrated among more advantaged women. Zonal awareness estimates, particularly for the North West, should be interpreted with caution. Because the data are cross-sectional and self-reported, these associations are not causal. Approaches that make HBV testing routinely available and affordable, particularly within antenatal care, warrant evaluation.
No takes yet. Share an insight, caveat, or question.
Ezugwu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: